SCHEMBL27369136

SCHEMBL27369136

CCCc1cn(CC)c(=O)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 1/20 0.37
HSD17B10 Q99714 3/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 2/20 0.34
GABRA2 P47869 1/20 0.34
GABRB2 P47870 1/20 0.34
CREBBP Q92793 1/20 0.33
PDE1A P54750 2/20 0.32
PDE1B Q01064 2/20 0.32
PDE1C Q14123 2/20 0.32
JAK2 O60674 1/20 0.32
ROCK2 O75116 1/20 0.32
PIM1 P11309 1/20 0.32
GSK3B P49841 1/20 0.32
ALDH1A1 P00352 3/20 0.32
BACE1 P56817 1/20 0.32
BMPR1B O00238 1/20 0.32
BMPR1A P36894 1/20 0.32
ACVRL1 P37023 1/20 0.32
ACVR1 Q04771 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21484499 0.83 HRH3 (0.38) MAPTCREBBPALDH1A1
SCHEMBL30500455 0.79 KDM5B (0.38) KDM5BHSD17B10MAPTKDM4ECREBBP
SCHEMBL24664733 0.79 SORT1 (0.33) MAPTCREBBPALDH1A1BMPR1BBMPR1A
SCHEMBL22757227 0.77 BRD4 (0.44) HSD17B10KDM4ECREBBPALDH1A1CYP1A2
SCHEMBL3986304 0.75 ALDH1A1 (0.38) HSD17B10MAPTKDM4ECREBBPPDE1A
SCHEMBL9797818 0.67 NOS2 (0.38) KDM5BKDM4EGABRA2GABRB2BACE1
SCHEMBL27369130 0.65 MGLL (0.43) MAPTKDM4ECREBBPALDH1A1
SCHEMBL10566 0.64 CPB2 (0.41) CYP2C19CYP2C9
SCHEMBL294175 0.63 KDM4E (0.32) KDM4E
SCHEMBL299637 0.63 NOS2 (0.36) HSD17B10KDM4EALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059665-A1 DIMERIC COMPOUNDS AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-03-21 WO disclosed